Table 2.
Risk of HF by LVH Status (N = 4543)
| Events/No. at Risk | Incidence Rate per 1000 Person‐years (95% CI) | Model 1, HRa (95% CI) | P Value | Model 2, HRb (95% CI) | P Value | |
|---|---|---|---|---|---|---|
| No ECG‐LVH | 1311/4375 | 24.8 (23.5‐26.2) | 1.0 | — | 1.0 | — |
| ECG‐LVH present | 69/168 | 43.2 (34.1‐54.7) | 1.80 (1.41‐2.30) | <0.0001 | 1.39 (1.08‐1.77) | 0.0097 |
| No LVH | 1271/4317 | 24.3 (23.0‐25.7) | 1.0 | — | 1.0 | — |
| Echo‐LVH present | 109/226 | 51.5 (42.7‐62.2) | 2.26 (1.85‐2.78) | <0.0001 | 1.52 (1.22‐1.89) | 0.0002 |
Abbreviations: BMI, body mass index; CHD, coronary heart disease; CI, confidence interval; DM, diabetes mellitus; ECG‐LVH, electrocardiographic left ventricular hypertrophy; echo‐LVH, echocardiographic left ventricular hypertrophy; HDL‐C, high‐density lipoprotein cholesterol; HF, heart failure; HR, hazard ratio; hs‐CRP, high‐sensitivity C‐reactive protein; LVH, left ventricular hypertrophy; SBP, systolic blood pressure.
a
Adjusted for age, sex, race, education, and income.
b
Adjusted for Model 1 covariates plus smoking status, SBP, DM, BMI, total cholesterol, HDL‐C, aspirin, statins, antihypertensive medications, log(hs‐CRP), and CHD.